Oral versus inhaled antibiotics for non-cystic fibrosis bronchiectasis

Sally Spencer; Lambert M. Felix; Stephen J. Milan; Rebecca Normansell; Pieter C. Goeminne; James D. Chalmers

doi:10.1002/14651858.CD012579

Oral versus inhaled antibiotics for non-cystic fibrosis bronchiectasis

Sally Spencer, Lambert M. Felix, Stephen J. Milan, Rebecca Normansell, Pieter C. Goeminne, James D. Chalmers

Molecular and Clinical Medicine

Research output: Contribution to journal › Review article › peer-review

6 Citations (Scopus)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the comparative efficacy and safety of oral versus inhaled antibiotics in the treatment of adults and children with non-cystic fibrosis bronchiectasis.

Original language	English
Article number	CD012579
Number of pages	11
Journal	Cochrane Database of Systematic Reviews
Issue number	3
DOIs	https://doi.org/10.1002/14651858.CD012579
Publication status	Published - 27 Mar 2017

ASJC Scopus subject areas

Medicine(all)
Pharmacology (medical)

Access to Document

10.1002/14651858.CD012579

Cite this

@article{f55ad90e17a64d218bf166546f73be9a,

title = "Oral versus inhaled antibiotics for non-cystic fibrosis bronchiectasis",

abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the comparative efficacy and safety of oral versus inhaled antibiotics in the treatment of adults and children with non-cystic fibrosis bronchiectasis.",

author = "Sally Spencer and Felix, {Lambert M.} and Milan, {Stephen J.} and Rebecca Normansell and Goeminne, {Pieter C.} and Chalmers, {James D.}",

note = "Drs Chalmers and Goeminne acknowledge support from the European Bronchiectasis Network (EMBARC) which is funded by the European Respiratory Society.",

year = "2017",

month = mar,

day = "27",

doi = "10.1002/14651858.CD012579",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley & Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Oral versus inhaled antibiotics for non-cystic fibrosis bronchiectasis

AU - Spencer, Sally

AU - Felix, Lambert M.

AU - Milan, Stephen J.

AU - Normansell, Rebecca

AU - Goeminne, Pieter C.

AU - Chalmers, James D.

N1 - Drs Chalmers and Goeminne acknowledge support from the European Bronchiectasis Network (EMBARC) which is funded by the European Respiratory Society.

PY - 2017/3/27

Y1 - 2017/3/27

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the comparative efficacy and safety of oral versus inhaled antibiotics in the treatment of adults and children with non-cystic fibrosis bronchiectasis.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the comparative efficacy and safety of oral versus inhaled antibiotics in the treatment of adults and children with non-cystic fibrosis bronchiectasis.

UR - http://www.scopus.com/inward/record.url?scp=85014858780&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD012579

DO - 10.1002/14651858.CD012579

M3 - Review article

AN - SCOPUS:85014858780

SN - 1469-493X

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 3

M1 - CD012579

ER -

Oral versus inhaled antibiotics for non-cystic fibrosis bronchiectasis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this